J.G. Brook

2.1k citations

76 papers · 1.7k · h-index 23

Impact in

Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
Endocrinology, Diabetes and Metabolism top 2%
- Diabetes, Cardiovascular Risks, and Lipoproteins

Papers in

Surgery 41
- Lipoproteins and Cardiovascular Health 28
- Cholesterol and Lipid Metabolism 12
Endocrinology, Diabetes and Metabolism 26
- Diabetes, Cardiovascular Risks, and Lipoproteins 21

Co-authors: Michael Aviram (12 shared papers)J. Oiknine (5 shared papers)Tony Hayek (5 shared papers)Gertrude Dankner (6 shared papers)Uri Cogan (4 shared papers)Yishai Levy (9 shared papers)S Keidar (6 shared papers)Jayson Rapoport (1 shared paper)
Journals: Atherosclerosis (10 papers)Postgraduate Medical Journal (5 papers)British Journal of Clinical Pharmacology (3 papers)Metabolism (3 papers)Lara D. Veeken (2 papers)
Partner nations: Israel United States United Kingdom

In The Last Decade

J.G. Brook

74 papers receiving 1.6k citations

Peers

Replace J. Stocks with:

J. Stocks United Kingdom

Ichiro Michishita Japan

Hiroshi Mokuno Japan

D. J. Betteridge United Kingdom

Gabriele Bittolo Bon Italy

Christian Landou Sweden

P Alessandrini Italy

Johannes Hulthe Sweden

John W. Gaubatz United States

Davide Noto Italy

J.G. Brook relative to J. Stocks United Kingdom J. Stocks's profile →

Citations per field

00.5×1.5×2.0×

J. Stocks · 1×

×1.1 222/201

BIOCH

×0.5 431/876

EDM

×0.7 413/628

CCM

×2.0 121/61

CB

×1.0 696/721

SURGE

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Countries citing papers authored by J.G. Brook

Since Specialization

Citations

This map shows the geographic impact of J.G. Brook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.G. Brook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.G. Brook more than expected).

Fields of papers citing papers by J.G. Brook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.G. Brook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.G. Brook. The network helps show where J.G. Brook may publish in the future.

Co-authors

The 25 scholars most cited alongside J.G. Brook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.G. Brook Line = papers co-authored together J.G. Brook links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Increased Plasma and Lipoprotein Lipid Peroxidation in apo E-Deficient Mice Biochemical and Biophysical Research Communications ·Tony Hayek, J. Oiknine, J.G. Brook, (unknown)	1994	157
2	Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: In vitro and in vivo studies Metabolism ·Michael Aviram, Gertrude Dankner, Uri Cogan, Edna Hochgraf, J.G. Brook	1992	119
3	Platelet activation by plasma lipoproteins Progress in Cardiovascular Diseases ·Michael Aviram, J.G. Brook	1987	115
4	Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II Atherosclerosis ·Shlomo Keidar, Marielle Kaplan, Chen Shapira, J.G. Brook, Michael Aviram	1994	98
5	Defective High-Density Lipoprotein Composition in Patients on Chronic Hemodialysis New England Journal of Medicine ·Jayson Rapoport, Michael Aviram, Cidio Chaimovitz, J.G. Brook	1978	98
6	Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies. British Journal of Clinical Pharmacology ·S Keidar, (unknown), Irit Maor, J. Oiknine, J.G. Brook	1994	59
7	Increased Low-Density Lipoprotein Levels After Splenectomy: A Role for the Spleen in Cholesterol Metabolism in Myeloproliferative Disorders The American Journal of the Medical Sciences ·(unknown), J.G. Brook, I. Tatarsky, Yishai Levy, A. Carter	1986	57
8	Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients Metabolism ·Edna Hochgraf, Yishai Levy, (unknown), J.G. Brook, Uri Cogan	1994	52
9	Role of HDL Apolipoprotein E in Cellular Cholesterol Efflux: Studies in Apo E Knockout Transgenic Mice Biochemical and Biophysical Research Communications ·Tony Hayek, J. Oiknine, J.G. Brook, (unknown)	1994	51
10	Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity. Arteriosclerosis An Official Journal of the American Heart Association Inc ·(unknown), Gertrude Dankner, J.G. Brook	1990	50
11	Accumulation of lipoprotein remnants in patients with chronic renal failure Atherosclerosis ·David Ron, I. Oren, (unknown), Ori S. Better, J.G. Brook	1983	47
12	HDL Apolipoprotein A-I Attenuates Oxidative Modification of Low Density Lipoprotein: Studies in Transgenic Mice Clinical Chemistry and Laboratory Medicine (CCLM) ·Tony Hayek, J. Oiknine, Gertrude Dankner, J.G. Brook, (unknown)	1995	43
13	High-density lipoprotein subfractions in normolipidemic patients with coronary atherosclerosis. Circulation ·J.G. Brook, (unknown), A Viener, E Shilansky, Wojciech T. Markiewicz	1982	38
14	HYPOCHOLESTEROLAEMIA AND ABNORMAL HIGH-DENSITY LIPOPROTEIN IN RHEUMATOID ARTHRITIS Lara D. Veeken ·Margalit Lorber, (unknown), Shai Linn, Y Scharf, J.G. Brook	1985	37
15	Platelet Lipoprotein Interactions Seminars in Thrombosis and Hemostasis ·J.G. Brook, (unknown)	1988	37
16	Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation European Journal of Clinical Investigation ·A Viener, J.G. Brook, Michael Aviram	1984	36
17	Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). American Journal of Public Health ·Shai Linn, Robinson Fulwood, Margaret D. Carroll, J.G. Brook, C L Johnson, W D Kalsbeek, Basil M. Rifkind	1991	34
18	Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia. PubMed ·Yishai Levy, Raya Leibowitz‐Amit, (unknown), J.G. Brook, Uri Cogan	1992	33
19	Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects Biochemical Journal ·A Shmulewitz, J.G. Brook, (unknown)	1984	27
20	Enhanced in vitro Platelet Aggregation in Hemodialysis Patients The Nephron journals/Nephron journals ·A Viener, (unknown), Ori S. Better, J.G. Brook	2008	25

About J.G. Brook

J.G. Brook is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research and Epidemiology, having authored 76 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (28 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Cholesterol and Lipid Metabolism (12 papers), Cancer, Lipids, and Metabolism (12 papers), Lipid metabolism and disorders (6 papers), Antioxidant Activity and Oxidative Stress (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Biochemistry (222 citations), Endocrinology, Diabetes and Metabolism (431 citations), Cardiology and Cardiovascular Medicine (413 citations), Clinical Biochemistry (121 citations) and Surgery (696 citations). J.G. Brook has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Michael Aviram, J. Oiknine, Tony Hayek, Gertrude Dankner, Uri Cogan, Yishai Levy, S Keidar, Jayson Rapoport, Cidio Chaimovitz and Shai Linn. Their work appears in journals such as Atherosclerosis, Postgraduate Medical Journal, British Journal of Clinical Pharmacology, Metabolism and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

J.G. Brook

Impact in

Papers in i

In The Last Decade

J.G. Brook

Peers

Countries citing papers authored by J.G. Brook

Fields of papers citing papers by J.G. Brook

All Works

About J.G. Brook

Explore authors with similar magnitude of impact

Papers in